Business · 1 sources covering this

Novo Shares Plunge 6% Despite CagriSema Beating Lilly In Diabetes Trial (HOLD)

CagriSema is a weekly injection that blends cagrilintide, a compound that mimics the pancreatic hormone amylin, with semaglutide, the active component in Wegovy.

Share:WhatsApp X Reddit Facebook LinkedIn

Coverage spectrum

0 L · 1 C · 0 R

How 1 sources are covering this

NDTVCenter·3h ago
Novo Shares Plunge 6% Despite CagriSema Beating Lilly In Diabetes Trial (HOLD)
CagriSema is a weekly injection that blends cagrilintide, a compound that mimics the pancreatic hormone amylin, with semaglutide, the active component in Wegovy.
Read at NDTV →

Embed this bias spectrum on your site

Paste this iframe wherever you'd like the widget to appear. Resizes responsively; no JS required.

<iframe
  src="https://hindustansphere.com/embed/cluster/2a1e2a2461bb6dd2a6e6a7ffa4a7fd4e9067072e"
  width="100%" height="320"
  style="border:0;max-width:680px"
  loading="lazy"
  title="Novo Shares Plunge 6% Despite CagriSema Beating Lilly In Diabetes Trial (HOLD)"></iframe>

Novo Shares Plunge 6% Despite CagriSema Beating Lilly In Diabetes Trial (HOLD)

How 1 sources are covering this

Novo Shares Plunge 6% Despite CagriSema Beating Lilly In Diabetes Trial (HOLD)

More from Business

US sets Sept 23 shutdown for Iran airlines; Bessent warns non-compliant entities will be ‘knocked out of dollar system’

Putin Plans To Attend Xi's APEC Summit And Skip G20 With Trump

Gujarat Police warns against Garba partner for rent: ‘Forehead kiss for ₹2,000, basic dance steps for ₹1,000’

Govt urges bank unions to call off strike, flags half-year closing impact

Reader

Trust & legal

Across the network